Takeda Pharmaceutical Co. Ltd.
4502Pharmaceuticals
¥6,471.00+2.60%As of Oct 29vs prior close
- Market cap
- $65.4B
- P/E (TTM)
- –
- P/E (FY1)
- 51.3×
- From 52W high
- 0.00%
- EPS (LTM)
- -¥105.53
- Revenue (LTM)
- ¥4.6T
- Net margin
- -3.54%
- Dividend yield
- 3.12%
Nomior Score
58
Crowded AscentTop 32% of the scored universe
Growth50
Quality43
Value31
Momentum94
Resilience58
Growth
+3.81%revenue a year over 3 fiscal years
YE23 ¥4TLTM ¥4.6T
Connections
Revenue to profitYE26
The net loss was 3% of revenue, wider by 6 pts on a year.